Form 4: AbbVie Director Susan Quaggin Trades Stock Units

AbbVie Inc. director Susan E. Quaggin reported transactions involving stock equivalent units, reflecting director fees and dividend reinvestment.

Summary

• Susan E. Quaggin, a Director at AbbVie Inc. (ABBV), has reported transactions related to her beneficial ownership of company securities.
• These transactions involve stock equivalent units, which are credited to an account under a grantor trust.
• The stock equivalent units earn returns equivalent to investments in AbbVie stock.
• The reporting person acquired 71 stock equivalent units on March 31, 2026, valued at $217.49 per unit.
• The total balance includes units acquired through a dividend reinvestment feature.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to director compensation rather than significant strategic shifts or performance indicators.

Positives

• Director Susan E. Quaggin's holdings reflect continued investment and participation in the company's equity through stock equivalent units.
• The dividend reinvestment feature indicates a mechanism for increasing beneficial ownership over time, aligning director interests with shareholders.

Future Outlook

The filing does not contain specific forward-looking statements or guidance. However, the nature of stock equivalent units and dividend reinvestment suggests a long-term alignment of director interests with the company's performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of stock equivalent units and grantor trusts is a common practice among public company directors to receive and manage compensation, aligning their interests with shareholders through equity-linked returns and dividend reinvestment.

Related Party Transactions

• Director fees are credited to a stock equivalent unit account under a grantor trust established by the director.

Stakeholder Impact

• Shareholders: The transactions reflect continued director participation in equity, potentially aligning interests. Dividend reinvestment benefits long-term holders.
• Employees: Indirect impact through the company's compensation structure for its board members.
• Management: Standard reporting procedure for executive and director compensation.

Key Dates

Keywords

AbbVie Inc., ABBV, Form 4, Director, Stock Equivalent Units, Beneficial Ownership, Grantor Trust, Dividend Reinvestment